EFPIA Unimpressed By Proposals For Tackling EU Medicines Shortages
Proposals Are Aimed At Informing Change At EU And National Level
Executive Summary
Further analysis is under way, but first impressions by EU R&D industry group EFPIA of policy proposals for tackling drug shortages are not good.
You may also be interested in...
Improving Medicines Availability Tops EU Regulators’ 2025 Workplan
The coordination group for EU mutual recognition and decentralized procedures is inviting stakeholder feedback on its priorities for the coming years.
German Tamoxifen Shortage Shows Consequences Of Cost Containment
Supply issues around breast cancer treatment tamoxifen in Germany demonstrate the damaging effects of European cost-containment measures, Medicines for Europe has warned, citing an “urgent need to revise unsustainable pricing and tendering policies.”
European Industry Proposes Incentive To Develop New Antimicrobials
With proposals for an overhaul of the EU medicines legislation due at the end of this year, EFPIA has published its formal response to the European Commission’s consultation with suggestions for facilitating new antibiotic development, testing new regulatory approaches to novel medicines, and tackling medicine shortages.